Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Prof. Iraqi is a molecular geneticist and world leader in the area of dissecting complex traits including hosts susceptibility to infection and chronic diseases. His current research is focused on understanding diseases etiology and host susceptibility to infectious and chronic diseases including Type 2 Diabetes and cardiovascular diseases (CVD) associated with obesity, Klebsiella pneumonia, Aspergillus fumigatus, dental infection (Periodontitis), gut microbiota and mapping modifiers for colon cancer development. Furthermore, he has an ongoing project for identifying the host genetic factors influencing immune response cell lineages in peripheral blood in the Collaborative Cross (CC) mouse population, which can lead to better predict host response to different diseases, based on genetic makeup (predictive genetic approach). His research projects are important for better understanding the host susceptibility to variety of infectious and chronic diseases, which will serve a step towards improving our knowledge of specific and general pathways and network systems, which can lead to establish better disease prevention and control strategies. For studying these diseases, he uses the mouse model, especially the unique and powerful mouse resource population known as the Collaborative Cross (CC), for studying systems genetics; including of performing quantitative trait loci (QTL) mapping, assessing gene expression profiles by RNAseq using deep sequence technology, which will lead of identifying and cloning the genes underlying the QTL, and subsequently indentify the ortholoug genes in human. He has number of ongoing joint collaborations with European scientists from Germany, the Netherlands, Switzerland, France, Spain and UK to use the CC mice for studying host susceptibility to different infectious and chronic diseases. Prof. Iraqi studied for his BSc. (Biology), MSc. (Biochemistry) and PhD (Molecular Genetics) at the Hebrew University at Jerusalem. He worked as a Postdoctoral for two years at the Hospital for Sick Children at Toronto, Canada, and two more years at the USDA, ARS- East Lansing, MI, before joining the International Livestock Research Institute (ILRI), based in Nairobi, Kenya as Scientist. In 2007, he moved to his current position as professor and Chairman of the department of Clinical Microbiology and Immunology, at the Faculty of Medicine at Tel-Aviv University. He has more than 135 publications on per reviewed Journals, and more than 25 book chapters. His current H-Index is 27.
Genetics of host susceptibility to Type 2 Development